Xcovery Email Format
Biotechnology ResearchFlorida, United States2-10 Employees
Xcovery is a biopharmaceutical company focused on discovering and developing cancer therapies to treat advanced tumors. Its lead product, ensartinib, targets ALK and is being studied for ALK-positive non-small cell lung cancer, with ongoing phase 2 and phase 3 clinical trials. The company aims to address a range of malignant diseases within oncology and works in collaboration with Betta Pharmaceuticals, reflecting its development in next-generation ALK inhibition. Based in Palm Beach Gardens, Florida, Xcovery operates with a small team and engages in international clinical development and partnerships to advance its pipeline.